Breaking Down Mental Health (Season 2) - Episode 3 Psychotropic Medications for Depression

Featured guest: Amy VandenBerg, PharmD, BCPP

Objectives

• Identify appropriate selective serotonin reuptake inhibitors for the management of depression in pediatric patients and how they work.
• Identify appropriate serotonin-norepinephrine reuptake inhibitors for the management of depression in pediatric patients and how they work.
• Discuss the black-box warning associated with these medications.
• Identify symptoms of serotonin syndrome.
• Identify symptoms of discontinuation syndrome.

Resources

• Selective serotonin reuptake inhibitors (StatPearls)
• Demystifying serotonin syndrome (or serotonin toxicity) (Canadian Family Physician)
• Antidepressant discontinuation syndrome (Canadian Medical Association Journal)
• Antidepressants and the FDA’s black-box warning: determining a rational public policy in the absence of sufficient evidence (AMA Journal of Ethics)
• Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison (Innovations in Clinical Neuroscience) 

Credits available: 0.5